Atrial Fibrillation: A Global Health Problem in the Spotlight

Atrial fibrillation is a cardiac arrhythmia that has emerged as a global health problem. With millions of patients worldwide suffering from this disease, atrial fibrillation affects people’s quality of life and health.

With the projected increase in life expectancy and the aging of the population, the prevalence of the disease is expected to increase in the coming years. This is also due to the increased occurrence of risk factors, such as obesity and hypertension, which contribute to the worsening of the condition. In addition to the physical consequences, the economic impact of atrial fibrillation is considerable. The increased demand for health services from patients dealing with the disease results in an overload of the health system. In this context, research and the scientific community are investing in finding advanced treatments and prevention strategies. The evolution of therapeutic approaches as well as the strengthening of prevention programs is expected to be a critical effort to address this global health problem.

The association of atrial fibrillation (AF) with serious complications, such as strokes, highlights the imperative need for early intervention. In this context, medical management, rhythm control, and anticoagulation are the initial pillars of treatment. However, in addition to the above, atrial fibrillation ablation emerges as the most important aspect of arrhythmia management, enhancing the patients’ quality of life.

The momentum of science in cardiology remains vital, with developments in the field guiding the effective prevention and treatment of AF. THE vaginal ablation fibrillation acquires a new dimension, harmonizing the treatment with the modern needs of patients.

Catalysis-Electrical isolation of pulmonary veins

Atrial fibrillation ablation surgery is performed using specialized catheters. They are inserted through peripheral veins and reach the heart, in the right atrium, painlessly. Through an interatrial septal stoma, access is gained to the left atrium, where the pulmonary veins and foci that cause atrial fibrillation are located. Through special catheters, controlled lesions are created to electrically isolate the pulmonary veins from the left atrium. The procedure takes about 1-2 hours.

Personalizing Therapy

Atrial fibrillation ablation offers individualized solutions for each patient. If persistent atrial fibrillation is observed, a second operation may be required to cause additional damage to the left atrium. It is important to mention that, in addition to interventional treatments, anticoagulation plays a vital role in the prevention of AF-related strokes.

At the Crossroads of Science and Practice

The techniques and means used in the ablation of atrial fibrillation are constantly improving, opening new perspectives in arrhythmology. The continuous development of technologies and the introduction of new catheters and electroanatomical mapping systems enhance the efficiency and safety of the operation. Today, patients have three different AF ablation technologies available to them:

1. RF ablation (radiofrequency ablation)
2. Cryoballoon ablation
3. Pulsed Field Ablation (PFA)

Each of these technologies offers unique advantages, paving the way for customized solutions. It is important to mention that all these techniques are carried out under the supervision of the 7th Cardiology Clinic of HYGEIA, under the direction of Mr. Michalis Koutouzis, distinguished for his vast experience in Interventional Cardiology.

Atrial fibrillation ablation opens new horizons in the treatment of arrhythmia and gives new hope to patients struggling with its effects. As science meets practice, therapeutic vision becomes reality and shapes a better tomorrow for us all. With the enhanced role of ablation in arrhythmia management and a holistic approach to patient care, we are at a critical juncture that may reshape the future of AF management.

Dr. Konstantinos Vlachos, an experienced Cardiologist and Specialized Arrhythmologist, specializing in Electrophysiology (Hôpital Cardiologique du Haut Lévêque – CHU de Bordeaux, IHU Liryc) is a pioneer in the field of arrhythmology, creating new hopes for patients and promoting the evolution of the therapeutic approach.